Pharmaceutical nanotechnology stands at the forefront of scientific innovation, merging nanoscience and technology to reshape drug development and healthcare interventions. Operating at the nanoscale, it exploits distinctive material properties to finely tune drug formulations, enhancing effectiveness while minimizing adverse effects. This interdisciplinary field not only addresses conventional pharmaceutical challenges but also opens novel avenues for advancements.
Pharmaceutical nanotechnology has also paved the way for personalized medicine. By tailoring drug formulations at the nanoscale, healthcare professionals can optimize treatment regimens based on individual patient characteristics. This level of customization holds great promise for more effective and patient-specific therapies.
Moreover, the diagnostic capabilities of pharmaceutical nanotechnology are remarkable. Nanoscale imaging agents and sensors enable early detection of diseases at the molecular level, allowing for timely interventions and monitoring of treatment responses. This integration of diagnostics and therapeutics is a hallmark of the nanotechnology revolution in pharmaceuticals. As research in this field progresses, addressing these challenges will be crucial to fully realize the potential of nanotechnology in transforming healthcare and pharmaceutical industries.
Pharmaceutical nanotechnology offers a diverse range of applications that redefine drug development, delivery, and diagnostic processes. Some notable applications include:
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia